These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 19672551)

  • 1. Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis.
    Kawada N; Imanaka K; Kawaguchi T; Tamai C; Ishihara R; Matsunaga T; Gotoh K; Yamada T; Tomita Y
    J Gastroenterol; 2009; 44(12):1190-4. PubMed ID: 19672551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review.
    Takuma Y; Nouso K
    World J Gastroenterol; 2010 Mar; 16(12):1436-41. PubMed ID: 20333782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
    Aby E; Phan J; Truong E; Grotts J; Saab S
    J Clin Gastroenterol; 2019 Feb; 53(2):142-146. PubMed ID: 29912761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of hepatocellular carcinoma patients with alcoholic liver disease and nonalcoholic steatohepatitis.
    Hashimoto E; Taniai M; Kaneda H; Tokushige K; Hasegawa K; Okuda H; Shiratori K; Takasaki K
    Alcohol Clin Exp Res; 2004 Aug; 28(8 Suppl Proceedings):164S-168S. PubMed ID: 15318106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?
    Chagas AL; Kikuchi LO; Oliveira CP; Vezozzo DC; Mello ES; Oliveira AC; Cella LC; Herman P; Bachella T; Caldwell SH; Alves VA; Carrilho FJ
    Braz J Med Biol Res; 2009 Oct; 42(10):958-62. PubMed ID: 19787150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.
    Yatsuji S; Hashimoto E; Tobari M; Taniai M; Tokushige K; Shiratori K
    J Gastroenterol Hepatol; 2009 Feb; 24(2):248-54. PubMed ID: 19032450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The characteristics and risk factors of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis.
    Tobari M; Hashimoto E; Taniai M; Kodama K; Kogiso T; Tokushige K; Yamamoto M; Takayoshi N; Satoshi K; Tatsuo A
    J Gastroenterol Hepatol; 2020 May; 35(5):862-869. PubMed ID: 31597206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Two cases of patients with hepatocellular carcinoma (HCC) that developed in cryptogenic cirrhosis suggestive of nonalcoholic steatohepatitis (NASH) as background liver disease after clinical courses of 26 years].
    Tsutsumi K; Nakayama H; Sakai Y; Kojima Y; Dairaku N; Ojima T; Kusano M; Ikeya S; Sugai Y; Hiwatashi N
    Nihon Shokakibyo Gakkai Zasshi; 2007 May; 104(5):690-7. PubMed ID: 17485950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of apoptosis inhibitor of macrophage is a sensitive diagnostic marker for NASH-associated hepatocellular carcinoma.
    Koyama N; Yamazaki T; Kanetsuki Y; Hirota J; Asai T; Mitsumoto Y; Mizuno M; Shima T; Kanbara Y; Arai S; Miyazaki T; Okanoue T
    J Gastroenterol; 2018 Jun; 53(6):770-779. PubMed ID: 29086016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
    Perumpail RB; Wong RJ; Ahmed A; Harrison SA
    Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma with nonalcoholic steatohepatitis.
    Mori S; Yamasaki T; Sakaida I; Takami T; Sakaguchi E; Kimura T; Kurokawa F; Maeyama S; Okita K
    J Gastroenterol; 2004; 39(4):391-6. PubMed ID: 15168253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C.
    Tokushige K; Hashimoto E; Yatsuji S; Tobari M; Taniai M; Torii N; Shiratori K
    J Gastroenterol; 2010 Sep; 45(9):960-7. PubMed ID: 20376504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.
    Tanaka S; Miyanishi K; Kobune M; Kawano Y; Hoki T; Kubo T; Hayashi T; Sato T; Sato Y; Takimoto R; Kato J
    J Gastroenterol; 2013 Nov; 48(11):1249-58. PubMed ID: 23329365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
    Ascha MS; Hanouneh IA; Lopez R; Tamimi TA; Feldstein AF; Zein NN
    Hepatology; 2010 Jun; 51(6):1972-8. PubMed ID: 20209604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.
    Zen Y; Katayanagi K; Tsuneyama K; Harada K; Araki I; Nakanuma Y
    Pathol Int; 2001 Feb; 51(2):127-31. PubMed ID: 11169153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases.
    Stine JG; Wentworth BJ; Zimmet A; Rinella ME; Loomba R; Caldwell SH; Argo CK
    Aliment Pharmacol Ther; 2018 Oct; 48(7):696-703. PubMed ID: 30136293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
    Hashimoto E; Yatsuji S; Tobari M; Taniai M; Torii N; Tokushige K; Shiratori K
    J Gastroenterol; 2009; 44 Suppl 19():89-95. PubMed ID: 19148800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary liver cancers with nonalcoholic steatohepatitis.
    Hashizume H; Sato K; Takagi H; Hirokawa T; Kojima A; Sohara N; Kakizaki S; Mochida Y; Shimura T; Sunose Y; Ohwada S; Mori M
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):827-34. PubMed ID: 17873605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Type 2 Diabetes on Oncologic Outcomes of Hepatocellular Carcinomas in Non-Cirrhotic, Non-alcoholic Steatohepatitis: a Matched-Pair Analysis.
    Billeter AT; Müller PC; Albrecht T; Roessler S; Löffler M; Lemekhova A; Mehrabi A; Müller-Stich BP; Hoffmann K
    J Gastrointest Surg; 2021 May; 25(5):1193-1202. PubMed ID: 32378092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.